178 related articles for article (PubMed ID: 28411177)
21. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of BRAF mutation in thyroid papillary cancer.
Fernandez IJ; Piccin O; Sciascia S; Cavicchi O; Repaci A; Vicennati V; Fiorentino M
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):919-25. PubMed ID: 23482475
[TBL] [Abstract][Full Text] [Related]
24. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
Lew M; Pang JC; Roh MH; Jing X
Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
26. Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.
Baser H; Topaloglu O; Tam AA; Alkan A; Kilicarslan A; Ersoy R; Cakir B
Endocr Pathol; 2016 Sep; 27(3):233-42. PubMed ID: 27256097
[TBL] [Abstract][Full Text] [Related]
27. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
28. Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.
Pyo JS; Kang G; Kim DH; Chae SW; Park C; Kim K; Do SI; Lee HJ; Kim JH; Sohn JH
Pathol Res Pract; 2013 Apr; 209(4):228-32. PubMed ID: 23528368
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
[No Abstract] [Full Text] [Related]
31. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
32. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
Kim Y; Kim MH; Jeon S; Kim J; Kim C; Bae JS; Jung CK
PLoS One; 2017; 12(3):e0174737. PubMed ID: 28358874
[TBL] [Abstract][Full Text] [Related]
34. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration.
Boonyaarunnate T; Olson MT; Bishop JA; Yang GC; Ali SZ
Acta Cytol; 2013; 57(2):127-33. PubMed ID: 23406819
[TBL] [Abstract][Full Text] [Related]
35. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
[TBL] [Abstract][Full Text] [Related]
36. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
37. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
[TBL] [Abstract][Full Text] [Related]
39. CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.
Chao TT; Maa HC; Wang CY; Pei D; Liang YJ; Yang YF; Chou SJ; Chen YL
APMIS; 2016 Dec; 124(12):1031-1037. PubMed ID: 27649840
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]